Neuberg Diagnostics secures Rs 940 crores from Kotak Alt
Neuberg Diagnostics has secured an investment of Rs 940 crores from Kotak Alt in the primary fund-raise.
Speaking about the fundraise, Dr GSK Velu, Founder and MD of Neuberg Diagnostics, said, “We are thrilled to announce that Neuberg Diagnostics has secured an investment from Kotak Alt marking a significant milestone in our journey toward becoming one of the largest diagnostics chains of Indian origin. This funding will enable us to enhance our capabilities in the areas of personalised medicine, integrated diagnostics and inorganically expand our footprint across the country. As we prepare for an IPO, we remain committed to making high-quality diagnostics accessible to all, ensuring that our services continue to meet the evolving needs of clinicians and patients.”
Rahul Shah, Partner at Kotak Alt said, “We are excited to partner with Neuberg Diagnostics as they work to transform the diagnostics landscape in India. The investment reflects our confidence in Neuberg's vision and potential. We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and help the Company get ready for their upcoming IPO. This investment solidifies our commitment to supporting quality healthcare solutions that improve patient outcomes and accessibility.”
o3 Capital acted as the exclusive financial advisor to Neuberg Diagnostics for their fundraise from Kotak Alt
Read also: Neuberg Diagnostics inaugrates integrated diagnostics centre in Raipur
